(EMAILWIRE.COM, August 20, 2009 ) New Delhi, India - According to our new research report, “Insulin Delivery Systems Market Analysis (2008-2012)”, technological advancements in insulin delivery methods across the globe are fueling growth in the global insulin delivery device market. With increasing prevalence of diabetes, the global insulin market is expected to grow at a CAGR of around 15% during 2010-2012 to post a value of around US$ 18.5 Billion by 2012; correspondingly the insulin delivery device market will also grow at the same pace. Currently, the market is characterized by developments of low cost insulin delivery system.

We have done extensive research on the global insulin market in order to identify trends undergoing in the key markets. According to the study, insulin pen is dominating the market with more than 56% of insulin unit delivered through insulin pens. This trend is likely to continue in near future as customers prefer less painful delivery methods. Various other factors such as increasing prevalence of lifestyle diseases and increasing penetration of health insurance have strongly supported the growth of insulin pen market

We have observed that at regional level, US holds the major market share of insulin delivery devices. But this trend is likely to change in near future as companies are shifting their focus to the Asian and Latin American countries by developing cheaper methods of insulin delivery. Moreover, developing countries are expected to drive the future growth as most of the markets are untapped there.

Our study analyzes the key markets and segments of the Industry to give a brief overview of the global insulin delivery device market. According to our industry experts, several steps should be taken by governments to simplify the approval system to promote investment in dedicated research and development. “Insulin Delivery Systems Market Analysis (2008-2012)” also describes factors restraining the industry growth and provides rational analysis along with forecast of different segments. The report gives valuable information to pharmaceutical and biotech companies planning to enter in this highly lucrative market.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM207.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.

Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.